Vittorio Gebbia

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Pisano Carmela; Morabito Alessandro; Sorio Roberto; Breda Enrico; Lauria Rossella; Gebbia Vittorio; Scaltriti Laura; Scalone Simona; Zagonel Vittorina; Greggi Stefano; Beneduce Gerardo; Losito Simona; Gallo Ciro; Di Maio Massimo; Forestieri Valeria; Pignata Sandro
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
Mercadante Sebastiano; Gebbia Vittorio; David Fabrizio; Aielli Federica; Verna Lucilla; Casuccio Alessandra; Porzio Giampiero; Mangione Salvatore; Ferrera Patrizia
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.
Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vittorio Gebbia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Pisano Carmela; Morabito Alessandro; Sorio Roberto; Breda Enrico; Lauria Rossella; Gebbia Vittorio; Scaltriti Laura; Scalone Simona; Zagonel Vittorina; Greggi Stefano; Beneduce Gerardo; Losito Simona; Gallo Ciro; Di Maio Massimo; Forestieri Valeria; Pignata Sandro
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
Cancer chemotherapy and pharmacology 2009;64(5):1021-7.
2009: Mercadante Sebastiano; Gebbia Vittorio; David Fabrizio; Aielli Federica; Verna Lucilla; Casuccio Alessandra; Porzio Giampiero; Mangione Salvatore; Ferrera Patrizia
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.
The journal of pain : official journal of the American Pain Society 2009;10(6):594-600.
2009: Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer research 2009;29(5):1841-5.
2009: Di Maio Massimo; Chiodini Paolo; Georgoulias Vassilis; Hatzidaki Dora; Takeda Koji; Wachters Floris M; Gebbia Vittorio; Smit Egbert F; Morabito Alessandro; Gallo Ciro; Perrone Francesco; Gridelli Cesare
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Gebbia Vittorio; Gridelli Cesare; Verusio Claudio; Frontini Luciano; Aitini Enrico; Daniele Bruno; Gamucci Teresa; Mancuso Gianfranco; Di Maio Massimo; Gallo Ciro; Perrone Francesco; Morabito Alessandro
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
Lung cancer (Amsterdam, Netherlands) 2009;63(2):251-8.
2008: Gebbia Vittorio
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma]
Tumori 2008;94(6):Suppl 31-7.
2008: Mercadante Sebastiano; Porzio Giampiero; Ferrera Patrizia; Fulfaro Fabio; Aielli Federica; Verna Lucilla; Villari Patrizia; Ficorella Corrado; Gebbia Vittorio; Riina Salvatore; Casuccio Alessandra; Mangione Salvatore
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
European journal of pain (London, England) 2008;12(8):1040-6.
2008: Gebbia Vittorio; Galetta Domenico; Lorusso Vito; Caruso Michele; Verderame Francesco; Pezzella Giuseppe; Borsellino Nicolò; Durini Ernesto; Valenza Roberto; Agostara Biagio; Colucci Giuseppe;
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Lung cancer (Amsterdam, Netherlands) 2008;61(3):369-77.
2008: Gebbia Vittorio
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
Expert opinion on pharmacotherapy 2008;9(8):1321-37.
2008: Gebbia Vittorio; Di Gregorio Carlo; Attard Marco
Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report.
Journal of medical case reports 2008;2():132.
2007: De Vita F; Giuliani F; Orditura M; Maiello E; Galizia G; Di Martino N; Montemurro F; Cartenì G; Manzione L; Romito S; Gebbia V; Ciardiello F; Catalano G; Colucci G;
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1354-8.
2007: Maiello E; Giuliani F; Gebbia V; Piano A; Agueli R; Colucci G
Cetuximab: clinical results in colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi8-10.
2007: Gebbia V; Giuliani F; Valori V M; Agueli R; Colucci G; Maiello E
Cetuximab in squamous cell head and neck carcinomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi5-7.
2007: Gebbia V; Maiello E; Giuliani F; Borsellino N; Caruso M; Di Maggio G; Ferraù F; Bordonaro R; Verderame F; Tralongo P; Di Cristina L; Agueli R; Russo P; Colucci G
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi124-7.
2007: Gridelli Cesare; Gallo Ciro; Ceribelli Anna; Gebbia Vittorio; Gamucci Teresa; Ciardiello Fortunato; Carozza Francesco; Favaretto Adolfo; Daniele Bruno; Galetta Domenico; Barbera Santi; Rosetti Francesco; Rossi Antonio; Maione Paolo; Cognetti Francesco; Testa Antonio; Di Maio Massimo; Morabito Alessandro; Perrone Francesco;
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
2007: Gralla Richard J; Gatzemeier Ulrich; Gebbia Vittorio; Huber Rudolf; O'Brien Mary; Puozzo Christian
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
Drugs 2007;67(10):1403-10.
2006: Tralongo Paolo; Di Mari Anna; Agueli Roberta; Gebbia Vittorio
Oral vinorelbine may not induce acute pain at the tumor site.
Journal of pain and symptom management 2006;32(3):197-9.
2006: Gebbia Vittorio; Caruso Michele; Borsellino Nicolo; Ajello Rosanna; Tirrito Maria Lina; Chiarenza Maurizio; Valenza Roberto; Verderame Francesco; Varvara Francesca; Marrazzo Antonio; Bajardi Eugenia; Ferrao Francesco; Bordonaro Roberto; Tralongo Paolo
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Anticancer research 2006;26(4B):3143-50.
2006: Giuliani F; Gebbia V; Maiello E; Borsellino N; Bajardi E; Colucci G;
Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii73-7.
2006: Gebbia V; Verderame F; Ferraù F; Bordonaro R; Callari A; Caruso M; Tirrito M L; Valenza R; Cicero G; Borsellino N; Tralongo P
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii60-5.
2006: Maiello E; Giuliani F; Gebbia V; Di Renzo N; Pezzella G; Romito S; Mallamaci R; Lopez M; Colucci G;
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii55-9.
2006: Savio Giuseppina; Laudani Agata; Leonardi Vita; Pepe Alessio; Scianna Caterina; Gebbia Vittorio; Agostara Biagio
Treatment of metastatic breast cancer with vinorelbine and docetaxel.
American journal of clinical oncology 2006;29(3):276-80.
2006: Gebbia Vittorio; Del Prete Salvatore; Borsellino Nicolò; Ferraù Francesco; Tralongo Paolo; Verderame Francesco; Leonardi Vita; Capasso Elena; Maiello Evaristo; Bordonaro Roberto; Stinco Sergio; Agostara Biagio; Barone Carlo
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience.
Clinical colorectal cancer 2006;5(6):422-8.
2006: Gebbia V; Oniga F; Agueli R; Paccagnella A
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii83-87.
2006: Pignata Sandro; Scambia Giovanni; Savarese Antonella; Breda Enrico; Scollo Paolo; De Vivo Rocco; Rossi Emanuela; Gebbia Vittorio; Natale Donato; Del Gaizo Filomena; Naglieri Emanuele; Ferro Antonella; Musso Pietro; D'Arco Alfonso Maria; Sorio Roberto; Pisano Carmela; Di Maio Massimo; Signoriello Giuseppe; Annunziata Annalisa; Perrone Francesco;
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.
BMC cancer 2006;6():202.
2005: Gebbia Vittorio; Agueli Roberta
Chemotherapy for endometrial carcinoma.
La Tunisie médicale 2005;83 Suppl 12():34-5.
2005: Giuliani Francesco; Molica Stefano; Maiello Evaristo; Battaglia C; Gebbia Vittorio; Di Bisceglie Maurizio; Vinciarelli Gianluca; Gebbia Nicola; Colucci Giuseppe;
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
American journal of clinical oncology 2005;28(6):581-5.
2005: Lorusso Vito; Gebbia Vittorio; Spada Massimiliano; Guida Michele; Cassano Grazia; Brunetti Cosimo; Germano Domenico; Nettis Giuseppe; Izzi Giovanni; Galetta Domenico; Giampaglia Marianna; Silvestris Nicola; Colucci Giuseppe
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Oncology reports 2005;14(6):1547-51.
2005: Galetta Domenico; Giotta Francesco; Rosati Gerardo; Gebbia Vittorio; Manzione Luigi; Di Bisceglie Maurizio; Borsellino Nicola; Colucci Giuseppe
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
Anticancer research 2005;25(6C):4445-9.
2005: Di Maio Massimo; Gridelli Cesare; Gallo Ciro; Shepherd Frances; Piantedosi Franco Vito; Cigolari Silvio; Manzione Luigi; Illiano Alfonso; Barbera Santi; Robbiati Sergio Federico; Frontini Luciano; Piazza Elena; Ianniello Giovanni Pietro; Veltri Enzo; Castiglione Federico; Rosetti Francesco; Gebbia Vittorio; Seymour Lesley; Chiodini Paolo; Perrone Francesco
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
The lancet oncology 2005;6(9):669-77.
2005: Gebbia Vittorio; Puozzo Christian
Oral versus intravenous vinorelbine: clinical safety profile.
Expert opinion on drug safety 2005;4(5):915-28.
2005: Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Borsellino N; Cartenì G; Pezzella G; Manzione L; Romito S; Lopez M; Colucci G;
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv56-60.
2005: Gebbia V; Galetta D; De Marinis F
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv123-131.
2005: Gridelli C; Rossi A; Galetta D; Maione P; Ferrara C; Guerriero C; Del Gaizo F; Nicolella D; Colantuoni G; Gebbia V; Colucci G
Italian clinical research in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv110-115.
2005: Iaffaioli R V; Formato R; Tortoriello A; Del Prete S; Caraglia M; Pappagallo G; Pisano A; Gebbia V; Fanelli F; Ianniello G; Cigolari S; Pizza C; Marano O; Pezzella G; Pedicini T; Febbraro A; Incoronato P; Manzione L; Ferrari E; Marzano N; Quattrin S; Pisconti S; Nasti G; Giotta G; Colucci G;
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
British journal of cancer 2005;92(9):1621-5.
2005: Lorusso Vito; Crucitta Enrico; Silvestris Nicola; Rosati G; Manzione L; De Lena M; Palmeri S; Gebbia V; Mancarella S; Sobrero A; Pezzella G; Comella P; Mangiameli A; Muci D;
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.
Oncology reports 2005;13(2):283-7.
2004: Laudani Agata; Gebbia Vittorio; Leonardi Vita; Savio Giuseppina; Borsellino Nicola; Cusimano Maria Pia; Calabria Caterina; Stefano Rosaria; Agostara Biagio
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma.
Anticancer research 2004;24(2C):1139-42.
2003: Gebbia Vittorio; Di Marco Pietro; Citarrella Pietro
Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin.
Critical reviews in oncology/hematology 2003;48(Suppl):S49-55.
2003: Giuliani Francesco; Gebbia Vittorio; De Vita Francesco; Maiello Evaristo; Di Bisceglie Maurizio; Catalano Giuseppe; Gebbia Nicolo; Colucci Giuseppe
Docetaxel as salvage therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.).
Anticancer research 2003;23(5b):4219-22.
2003: Gridelli Cesare; Gallo Ciro; Shepherd Frances A; Illiano Alfonso; Piantedosi Francovito; Robbiati Sergio Federico; Manzione Luigi; Barbera Santi; Frontini Luciano; Veltri Enzo; Findlay Brian; Cigolari Silvio; Myers Robert; Ianniello Giovanni P; Gebbia Vittorio; Gasparini Giampietro; Fava Sergio; Hirsh Vera; Bezjak Andrea; Seymour Lesley; Perrone Francesco
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2003: Gebbia Vittorio; Di Marco Pietro; Borsellino Nicolò; Gebbia Nicolò; Valerio Maria Rosaria; Fallica Giuseppina; Tirrito Maria Lina; Valenza Roberto; Citarrella Pietro; Benedetti Panici Pierluigi
Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II study.
Anti-cancer drugs 2003;14(5):359-64.
2003: Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(5):326-31.
2003: Rossi Antonio; Gridelli Cesare; Gebbia Vittorio; Rosati Gerardo; Tortoriello Anna; Maione Paolo; Borsellino Nicola; Rossi Nestore; Pisano Agata; Colantuoni Giuseppe; Iaffaioli Rosario Vincenzo; Castaldo Vincenzo; Manzione Luigi
Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
Anticancer research 2003;23(2C):1657-64.
2003: Gridelli Cesare; Perrone Francesco; Gallo Ciro; Cigolari Silvio; Rossi Antonio; Piantedosi Francovito; Barbera Santi; Ferraù Francesco; Piazza Elena; Rosetti Francesco; Clerici Maurizia; Bertetto Oscar; Robbiati Sergio Federico; Frontini Luciano; Sacco Cosimo; Castiglione Federico; Favaretto Adolfo; Novello Silvia; Migliorino Maria Rita; Gasparini Giampietro; Galetta Domenico; Iaffaioli Rosario Vincenzo; Gebbia Vittorio;
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Journal of the National Cancer Institute 2003;95(5):362-72.
2003: Gebbia Vittorio; Galetta Domenico; Caruso Michele; Verderame Francesco; Pezzella Giuseppe; Valdesi Matteo; Borsellino Nicolò; Pandolfo Giuseppe; Durini Ernesto; Rinaldi Massimo; Loizzi Michele; Gebbia Nicola; Valenza Roberto; Tirrito Maria Lina; Varvara Francesca; Colucci Giuseppe;
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):179-89.
2003: Cocconi G; Passalacqua R; Foladore S; Carlini P; Acito L; Maiello E; Marchi M; Gebbia V; Di Sarra S; Beretta M; Bacchi M
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
Melanoma research 2003;13(1):73-9.
2003: Gebbia Vittorio; Blasi Livio; Borsellino Nicolo; Caruso Michele; Leonardi Vita; Agostara Biagio; Valenza Roberto
Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomised phase II study.
Anticancer research 2003;23(1B):765-71.
2003: Gebbia Vittorio; Borsellino Nicolò; Testa Antonio; Tirrito Maria Lina; Ferrera Patrizia; Colombo Alfredo; Mauceri Gaetano; Marrazzo Antonio; Porretto Ferdinando; Musso Maurizio
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinoma.
Breast cancer research and treatment 2003;77(2):99-108.
2002: Galetta Domenico; Gebbia Vittorio; Giotta Francesco; Durini Ernesto; Romito Sante; Borsellino Nicola; Cazzato Carlo; Pezzella Giuseppe; Colucci Giuseppe
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):79-84.
2002: Gebbia Vittorio; Galetta Domenico; Riccardi Fernando; Gridelli Cesare; Durini Ernesto; Borsellino Nicolò; Gebbia Nicolò; Valdesi Matteo; Caruso Michele; Valenza Roberto; Pezzella Giuseppe; Colucci Giuseppe;
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Lung cancer (Amsterdam, Netherlands) 2002;37(2):179-87.
2002: Vici Patrizia; Colucci Giuseppe; Gebbia Vittorio; Amodio Antonella; Giotta Francesco; Belli Franca; Conti Francesca; Gebbia Nicola; Pezzella Giuseppe; Valerio Maria Rosaria; Brandi Mario; Pisconti Salvatore; Durini Ernesto; Giannarelli Diana; Lopez Massimo
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2689-94.
2002: Citarrella Pietro; Gebbia Vittorio; Teresi Michele; Miceli Salvatore; Sciortino Giovanna; Vaglica Marina; Pizzardi Nicolina; Palmeri Sergio
Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.
Anticancer research 2002;22(2B):1183-5.
2002: Colucci Giuseppe; Giuliani Francesco; Gebbia Vittorio; Biglietto Maria; Rabitti Piergiorgio; Uomo Generoso; Cigolari Silvio; Testa Antonio; Maiello Evaristo; Lopez Massimo
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
Cancer 2002;94(4):902-10.
2002: Gebbia Vittoria; Caruso Michele; Testa Antonio; Mauceri Gaetano; Borsellino Nicolò; Chiarenza Maurizio; Pizzardi Nicoletta; Palmeri Sergio
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix.
Oncology 2002;63(1):31-7.
2002: Gebbia Vittorio; Mauceri Gaetano; Fallica Giuseppina; Borsellino Nicolò; Tirrito Maria Lina; Testa Antonio; Varvara Francesca; Colombo Alfredo; Ferrera Patrizia
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.
Oncology 2002;63(1):23-30.
2001: Gridelli C; Curcio C; Iaffaioli R V; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Anticancer research 2001;21(6A):4179-83.
2001: Gebbia V; Giuliani F; Maiello E; Colucci G; Verderame F; Borsellino N; Mauceri G; Caruso M; Tirrito M L; Valdesi M
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4089-91.
2001: Palmeri S; Leonardi V; Gebbia V; De Bella M T; Ferraù F; Faillú G; Spatafora M; Valenza R; Di Vita G; Vitello S; Carroccio R; Sciortino G; Vaglica M; Accurso V; Agostara B; Licata G
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):115-23.
2001: Gebbia V; Testa A; Borsellino N; Ferrera P; Tirrito M; Palmeri S
Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):767-72.
2001: Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2898-904.
2000: Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Cigolari S; Fortunato S; Pedicini T; Borsellino N; Lopez M; Colucci G
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1045-51.
2000: Mercadante S; Gebbia V; Marrazzo A; Filosto S
Anaemia in cancer: pathophysiology and treatment.
Cancer treatment reviews 2000;26(4):303-11.
2000: Valenza R; Leonardi V; Gebbia V; Agostara B
Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(4):495-6.
1999: Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
Anticancer research 1999;19(4C):3553-7.
1999: Colucci G; Giuliani F; Gebbia V; Testa A; Borsellino N; Lelli G; Fortunato S; Lopez M; Maiello E; Gebbia N
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
American journal of clinical oncology 1999;22(3):262-6.
1999: Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Anticancer research 1999;19(3B):2289-92.
1999: Gebbia V; Maiello E; Serravezza G; Giotta F; Testa A; Borsellino N; Pezzella G; Colucci G
5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Anticancer research 1999;19(2B):1407-10.
1999: Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
Cancer 1999;85(3):535-45.
1999: Gebbia V; Testa A; Borsellino N; Mauceri G; Varvara F; Tirrito M L; Sambataro D; Fallica G
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.
La Clinica terapeutica 1999;150(1):11-5.
1998: Di Gregorio C; Florena A M; Gebbia V; Moschella F
Mental nerve invasion by basal cell carcinoma of the chin: a case report.
Anticancer research 1998;18(6B):4723-6.
1998: Maiello E; Gebbia V; Giuliani F; Testa A; Giotta F; Gebbia N; Colucci G
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
La Clinica terapeutica 1998;149(5):351-5.
1998: Naglieri E; Gebbia V; Durini E; Lelli G; Abbate I; Selvaggi F P; Di Tonno P; Colucci G
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.
Anticancer research 1998;18(3B):2021-6.
1998: Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio A M; Maiorino L
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
British journal of cancer 1998;77(7):1149-54.
1997: Gebbia V; Borsellino N; Testa A; Latteri M A; Milia V; Valdesi M; Giotta F; Gebbia N; Colucci G
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM).
Anti-cancer drugs 1997;8(10):943-8.
1997: Gebbia V; Mantovani G; Farris A; Agostara B; Desogus A; Curreli L; Moschella F; Di Gregorio C; Bajetta E; Gebbia N
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
Cancer 1997;79(7):1394-400.
1997: Colucci G; Giotta F; Gebbia V; Riccardi F; Pezzella G; Durini E; Caruso M; Romito S; Gebbia N
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group.
Anti-cancer drugs 1997;8(3):257-64.
1997: Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
British journal of cancer 1997;76(11):1509-17.
1996: Gridelli C; D'Aprile M; Palmeri S; Curcio C; Rossi A; Gebbia V; Veltri E; Pepe R; Pistillucci G; Bianco A R
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
American journal of clinical oncology 1996;19(6):589-91.
1996: Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto A F; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco A R
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):821-6.
1996: Maiello E; Giotta F; Gebbia V; Testa A; Galetta D; Riccardi F; Gebbia N; Colucci G
Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients.
Anticancer research 1996;16(5B):3177-9.
1996: Gebbia V; Testa A; Cannata G; Gebbia N
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Anti-cancer drugs 1996;7(7):734-7.
1996: Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Cancer 1996;78(6):1300-7.
1996: Colucci G; Maiello E; Gebbia V; Cifarelli R A; Biglietto M; Pedicini A; Durini E; Giuliani F; Gebbia N
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM).
Oncology 1996;53(4):269-74.
1996: Gebbia V; Testa A; Majello E; Cannata G; Tirrito M L; Mastrandrea G; Feo M; Bajardi G; Colucci G; Gebbia N
Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma.
Anti-cancer drugs 1996;7(4):386-91.
1996: Gebbia V; Testa A; Gebbia N
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
British journal of cancer 1996;73(12):1576-80.
1996: Gebbia V; Galetta D; Majello E; Valenza R; Colucci G; Gebbia N
Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: a study by the Southern Italy Oncology Group (GOIM).
American journal of clinical oncology 1996;19(3):278-80.
1996: Gebbia V; Testa A; Cannata G; Gebbia N
Single agent paclitaxel in advanced squamous cell head and neck carcinoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):901-2.
1995: Gebbia V; Mantovani G; Agostara B; Contu A; Farris A; Colucci G; Cognetti F; Restivo G; Speciale R; Ferrero B
Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):987-91.
1995: Gebbia V; Testa A; Valenza R; Cannata G; Tirrito M L; Gebbia N
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Cancer 1995;76(10):1821-8.
1995: Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
British journal of cancer 1995;72(5):1245-50.
1995: Latteri M A; Cipolla C; Gebbia V; Lampasona G; Amato C; Gebbia N
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):432-4.
1995: Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1995;18(4):293-6.
1995: Di Gregorio C; Gebbia V; Florena A M; Franco V; Moschella F
Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck.
Anticancer research 1995;15(3):1107-15.
1994: Gebbia V; Valenza R; Testa A; Cipolla C; Latteri M; Curto G; Comande S; Buccellato C; Gebbia N
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas.
American journal of clinical oncology 1994;17(6):485-9.
1994: Gebbia V; Cannata G; Testa A; Curto G; Valenza R; Cipolla C; Latteri M A; Gebbia N
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
Cancer 1994;74(7):1945-52.
1994: Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
ORL; journal for oto-rhino-laryngology and its related specialties 1994;56(5):279-82.
1994: Gebbia V; Caruso M; Valenza R; Testa A; Cannata G; Verderame F; Cipolla C; Curto G; Oliveri D; Chiarenza M
Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma.
Anticancer research 1994;14(3B):1247-9.
1994: Gebbia V; Testa A; Valenza R; Latteri M; Bajardi G; Mastrandrea G; Cipolla C; Pischedda G; Curto G; Cannata G
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach.
Journal of chemotherapy (Florence, Italy) 1994;6(2):147-51.
1994: Gebbia V; Valenza R; Testa A; Cannata G; Borsellino N; Gebbia N
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy.
Anticancer research 1994;14(2B):731-4.
1994: Agostara B; Gebbia V; Testa A; Cusimano M P; Gebbia N; Callari A M
Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
Tumori 1994;80(1):33-6.
1994: Gebbia V; Valenza R; Testa A; Sciume C; Longo A; Cipolla C; Borsellino N; Leo P; Latteri M; Florena M
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
Journal of cancer research and clinical oncology 1994;120(9):550-2.
1994: Gebbia V; Testa A; Valenza R; Cannata G; Verderame F; Gebbia N
Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: report of unusual toxicity.
European journal of cancer (Oxford, England : 1990) 1994;30A(6):889.
1994: Gebbia V; Valenza R; Testa A; Cannata G; Verderame F; Gebbia N
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(11):1734-6.
1994: Callari A; Gebbia V; Testa A; Cusimano M P; Cipolla C; Amato C; Cannata G; Latteri M A; Garascia C; Gebbia N
A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
Acta oncologica (Stockholm, Sweden) 1994;33(8):925-9.
1993: Gebbia V; Testa A; Valenza R; Zerillo G; Restivo S; Cupido G; Ingria F; Barbaccia C; Spadafora G; Cannata G
A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma.
Oncology 1993;50(6):490-4.
1993: Gebbia V; Testa A; Borsellino N; Cannata G; Valenza R; Gebbia N
Pharmacological modulation of 5-fluorouracil and its clinical implications: an overview.
In vivo (Athens, Greece) 1993;7(6B):639-44.
1993: Gebbia V; Carreca I; Testa A; Valenza R; Curto G; Cannata G; Borsellino N; Latteri M A; Cipolla C; Florena M
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
Anti-cancer drugs 1993;4(4):443-5.
1993: Gebbia V; Agostara B; Callari A; Zerillo G; Restivo G; Speciale R; Cupido G; Ingria F; Spatafora G; Fazio L
Head and neck carcinoma with distant metastases: a retrospective analysis of 44 cases treated with cisplatin-based chemotherapeutic regimens.
Anticancer research 1993;13(4):1129-31.
1993: Gebbia V; Zerillo G; Restivo G; Speciale R; Cupido G; Lo Bue P; Ingria F; Gallina S; Spatafora G; Testa A
Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
British journal of cancer 1993;68(1):191-4.
1993: Gebbia V; Testa A; Valenza R; Borsellino N; Cipolla C; Cannata G; Curto G; Latteri M; Florena M; Gebbia N
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma.
Journal of chemotherapy (Florence, Italy) 1993;5(3):186-90.
1993: Gebbia V; Testa A; Valenza R; Cipolla C; Amato C; Latteri M; Gebbia N; Florena M
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
Anticancer research 1993;13(1):141-4.
1993: Russo A; Gebbia V; Palmeri S; Geraci P; Maneschi F; Guarnieri G; Carollo F; Leonardi V; Meli M; Gebbia N
Results of the combination of cisplatin, adriamycin and cyclophosphamide in the treatment of ovarian carcinoma.
European journal of gynaecological oncology 1993;14(3):228-33.
1993: Gebbia V; Testa A; Valenza R; Zerillo G; Restivo S; Ingria F; Cannata G; Gebbia N
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1358-9.
1992: Gebbia V; Gebbia N; Russo A; Testa A; Valenza R; Zerillo G; Ingria F; Spadafora G; Rausa L
Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy.
Anti-cancer drugs 1992;3(4):347-9.
1992: Gebbia V; Zerillo G; Gebbia N; Agostara B; Callari A; Rausa L
Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease.
Journal of chemotherapy (Florence, Italy) 1992;4(4):244-59.
1992: Gebbia V; Citarrella P; Miserendino V; Valenza R; Borsellino N; Pesta A; Pettit R; May S
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro.
Tumori 1992;78(3):167-71.
1992: Citarrella P; Gebbia V; Di Marco P; Tambone Reyes M; Noto G; Aricò M
Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
Journal of chemotherapy (Florence, Italy) 1992;4(1):56-8.
1992: Gebbia V; Russo A; Gebbia N; Rausa L; Ingria F; Spatafora G; Zerillo G; Cimino A; Pastorello T; Ferrara P
High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck.
Journal of cancer research and clinical oncology 1992;118(6):458-62.
1992: Palmeri S; Gebbia V; Russo A; Gebbia N; Rustum Y; Rausa L
Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma.
Cancer investigation 1992;10(6):497-504.
1992: Gebbia V; Valenza R; Testa A; Zerillo G; Restivo S; Cupido G; Ingria F; Spadafora G; Barbaccia C; Cannata G
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer.
Medical oncology and tumor pharmacotherapy 1992;9(4):165-8.
1991: Gebbia V; Russo A; Gebbia N; Valenza R; Testa A; Palmeri S; Rausa L
Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.
In vivo (Athens, Greece) 1991;5(6):579-81.
1991: Palmeri S; Gebbia V; Russo A; Gebbia N; Meli M; Rausa L
Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
Journal of chemotherapy (Florence, Italy) 1991;3(3):176-9.
1991: Palmeri S; Gebbia V; Russo A; Gebbia N; Rustum Y; Rausa L; Creaven P; Petrelli N
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma.
Journal of chemotherapy (Florence, Italy) 1991;3(3):170-5.
1991: Gebbia V; Palmeri S; Valenza R; Rausa L; Citarrella P
The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in golden Syrian hamsters.
In vivo (Athens, Greece) 1991;5(2):149-52.
1991: Palmeri S; Gebbia V
Combined 5-fluorouracil and recombinant alpha-2a-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study.
Journal of surgical oncology. Supplement 1991;2():134-6.
1991: Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
Journal of cancer research and clinical oncology 1991;117(3):266-8.
1991: Gridelli C; Pepe R; Palmeri S; Iacobelli S; Gentile M; Gebbia V; Garufi C; Airoma G; Palmieri G; Russo A
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1991;28(5):405-7.
1990: Gebbia V; Valenza R; Rausa L
The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.
Anticancer research 1990;10(6):1779-82.
1990: Palmeri S; Gebbia V; Rausa L
5-Fluorouracil and recombinant alpha interferon-2a in the treatment of advanced colorectal carcinoma: a dose optimization study.
Journal of chemotherapy (Florence, Italy) 1990;2(5):327-30.
1990: Gebbia V; Gebbia N; Rausa L; Sharkis S J; May W S
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():103-4.
1990: Citarrella P; Gebbia V; Miceli S; Palmeri S; Rausa L
Effect of human granulocyte colony stimulating factor (G-CSF) and reduced glutathione (GSH) on drug-induced leukopenia in golden Syrian hamsters.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():99-100.
1990: Palmeri S; Gebbia V; Russo A; Armata M G; Gebbia N; Rausa L
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.
British journal of cancer 1990;61(3):475-8.
1990: Palmeri S; Russo A; Gebbia V; Borsellino N; Gebbia N; Rustum Y; Rausa L
A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma.
Journal of chemotherapy (Florence, Italy) 1990;2 Suppl 1():28-32.
1990: Caruso C; Modica M A; Candore G; Di Giulio C; Galluzzo A; Giordano C; Di Marco P; Gebbia V; Tamone Reyes M; Citarrella P
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
Bollettino dell'Istituto sieroterapico milanese 1990;69(1):335-8.
1989: Gebbia V; Miserendino V; Miceli S; Colucci A; Reyes M T; Rausa L; Di Marco P; Citarrella P
Analysis of human dysplastic haematopoiesis in long-term bone marrow culture.
Blut 1989;59(5):442-8.
1989: Palmeri S; Gebbia V; Russo A; Gebbia N; Rausa L
Combination chemotherapy with cyclophosphamide, doxorubicin and vincristine in the treatment of stage III-IV small-cell lung cancer.
Journal of chemotherapy (Florence, Italy) 1989;1(5):346-9.
1989: Gebbia V; Bonaccorso R; Tambone Reyes M; Di Salvo V; Di Marco P; Citarrella P
Treatment of polycythemia vera with hydroxyurea.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1278-80.
1989: Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1276-8.
1989: Bonaccorso R; Teresi M; Gebbia V; Tambone Reyes M; Tinnirello D; Di Marco P; Citarrella P; Mansueto S
Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1266-8.
1989: Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
Alpha interferon in the treatment of hairy cell leukemia.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1264-5.
1989: Gebbia V; Colucci A; Citarrella P; Di Marco P; Miserendino V; Tambone Reyes M; Teresi M; Bonaccorso R; Rausa L; Mansueto S
The multipotential hematopoietic growth factors, bryostatins, inhibit human leukemia cell lines in vitro.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1161-3.
1989: Bonaccorso R; Gebbia V; Tambone Reyes M; Pappalardo M S; Peralta S; La Iuppa M; Teresi M; Di Marco P; Citarrella P; Mansueto S
Thymopentin (TP 5) in the management of patients with uremia.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):465-6.
1989: Gebbia V; Palmeri S; Russo A; Gebbia N; Rausa L
The effectiveness of combination chemotherapy with cisplatinum and etoposide in the treatment of advanced non-small cell lung cancer.
Journal of chemotherapy (Florence, Italy) 1989;1(3):203-6.
1989: Palmeri S; Gebbia V; Russo A; Gebbia N; Oliveri D; Rausa L
Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients.
Journal of cancer research and clinical oncology 1989;115(6):579-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vittorio Gebbia

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vittorio Gebbia (preview)

All Publications